首页> 外文期刊>Cardiovascular revascularization medicine: including molecular interventions >Intra-arterial injection of human embryonic stem cells in athymic rat hind limb ischemia model leads to arteriogenesis.
【24h】

Intra-arterial injection of human embryonic stem cells in athymic rat hind limb ischemia model leads to arteriogenesis.

机译:在无胸腺大鼠后肢缺血模型中动脉内注射人胚胎干细胞可导致动脉生成。

获取原文
获取原文并翻译 | 示例
           

摘要

Shear stress can enhance differentiation of human embryonic stem cells (hESC) to vascular cells. We tested the hypothesis that intra-arterial hESC injection will lead to arteriogenesis while intramuscular injection will have no effect on vascularization. METHODS AND RESULTS: The superficial femoral arteries were excised on both hind limbs in athymic rats. hESC (2x10(6)) were injected intra-arterially (shear stress) or intramuscular (no shear stress) in one limb after arterial excision. Blood flow, muscle perfusion, and number of arteries/mm(2) muscle were studied at 10 and 21 days after injection. Blood flow in the common iliac artery improved significantly at 10 days after intra-arterial injection of hESC (22+/-9%, P<.02), and tight muscle perfusion improved significantly both at 10 and 21 days (9+/-2%, 16+/-5% respectively, both P<.02). In comparison, intramuscular injection of hESC did not affect blood flow at 10 and 21 days (-3+/-10% and 4+/-6%, respectively), while perfusion showed no significant effect of hESC injection after 10 days (1+/-8%) and was increased 21 days after hESC injection (11+/-5%, P=.03). Arterial density did not improve after intra-arterial hESC injection at 10 days (15+/-13%, P=.15) and significantly improved at 21 days (13+/-4%, P<.05). No significant change was demonstrated after intramuscular injection. SUMMARY: Intra-arterial injection of hESC resulted in moderate improvement of flow and perfusion and increased number of arteries in the ischemic hind limb. No consistent change in perfusion, flow, and number of arteries was observed after intramuscular injection.
机译:剪应力可增强人类胚胎干细胞(hESC)向血管细胞的分化。我们测试了以下假设:动脉内hESC注射会导致动脉生成,而肌肉内注射对血管形成没有影响。方法和结果:切除无胸腺大鼠后肢的股浅动脉。在动脉切除后,将hESC(2x10(6))注射到一只肢体的动脉内(剪切应力)或肌肉内(无剪切应力)。在注射后第10天和第21天研究了血流,肌肉灌注和动脉数量/ mm(2)肌肉。动脉内注射hESC后第10天,总动脉的血流显着改善(22 +/- 9%,P <.02),第10天和第21天的紧密肌灌注显着改善(9 +/-)分别为2%,16 +/- 5%,均P <.02)。相比之下,肌注hESC不会在10天和21天影响血流量(分别为-3 +/- 10%和4 +/- 6%),而灌注显示在10天后对hESC注射没有明显影响(1 hESC注射后21天增加(+/- 8%)(11 +/- 5%,P = .03)。动脉内hESC注射后第10天,动脉密度没有改善(15 +/- 13%,P = .15),而在第21天时,动脉密度显着改善(13 +/- 4%,P <.05)。肌肉注射后未见明显变化。摘要:hESC的动脉内注射导致缺血性后肢的流量和灌注适度改善,并增加了动脉数量。肌肉注射后未观察到灌注,流量和动脉数目的一致变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号